BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21109483)

  • 1. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
    Fang L; Wang H; Zhou L; Yu D
    Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ induces stemness through non-canonical AKT-FOXO3a axis in oral squamous cell carcinoma.
    Li K; Yang L; Li J; Guan C; Zhang S; Lao X; Ouyang D; Zheng G; Gao S; Wang D; Liang Y; Liao G
    EBioMedicine; 2019 Oct; 48():70-80. PubMed ID: 31629677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
    Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
    Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
    J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSC126188 induces apoptosis of prostate cancer PC-3 cells through inhibition of Akt membrane translocation, FoxO3a activation, and RhoB transcription.
    Won KJ; Kim BK; Han G; Lee K; Jung YJ; Kim HM; Song KB; Chung KS; Won M
    Apoptosis; 2014 Jan; 19(1):179-90. PubMed ID: 24085402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
    Iamaroon A; Krisanaprakornkit S
    Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Akt/FOXO3a signaling by constitutively active FOXO3a suppresses growth of follicular thyroid cancer cell lines.
    Hong ZY; Lee HJ; Shin DY; Kim SK; Seo M; Lee EJ
    Cancer Lett; 2012 Jan; 314(1):34-40. PubMed ID: 21974806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a.
    Lee N; Tilija Pun N; Jang WJ; Bae JW; Jeong CH
    J Cell Mol Med; 2020 Jun; 24(12):7055-7066. PubMed ID: 32406610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
    Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
    Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of murine c-kit(pos) cardiac stem cells stimulated with IGF-1 is associated with Akt-1 mediated phosphorylation and nuclear export of FoxO3a and its effect on downstream cell cycle regulators.
    Johnson AM; Kartha CC
    Growth Factors; 2014 Apr; 32(2):53-62. PubMed ID: 24580070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling.
    Zhao GX; Xu LH; Pan H; Lin QR; Huang MY; Cai JY; Ouyang DY; He XH
    Oncotarget; 2015 Nov; 6(36):38952-66. PubMed ID: 26517515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
    Santo EE; Stroeken P; Sluis PV; Koster J; Versteeg R; Westerhout EM
    Cancer Res; 2013 Apr; 73(7):2189-98. PubMed ID: 23378341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3a: a novel player in thyroid carcinogenesis?
    Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
    Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.